(Q34486238)

2 August 2017

Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses (English)

1 reference

respiratory syncytial virus

2 August 2017

0 references

RSV major surface glycoprotein G

0 references

modulation by virus of host process

0 references

1

Jennifer Harcourt

1 reference

2 August 2017

5

Larry J Anderson

1 reference

2 August 2017

6

Ralph A Tripp

1 reference

2 August 2017

Rene Alvarez

2

1 reference

2 August 2017

Les P Jones

series ordinal

3

1 reference

2 August 2017

Christine Henderson

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

2 August 2017

Journal of Immunology

1 reference

2 August 2017

176

1 reference

2 August 2017

1600-1608

1 reference

2 August 2017

3

1 reference

Interferon-gamma stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells

2 August 2017

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Respiratory syncytial virus infection in elderly and high-risk adults

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Pathogenesis of respiratory syncytial virus infection

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Trafficking of natural killer cells

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Respiratory syncytial virus infection in human immunodeficiency virus-infected children

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations).

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

C and CX3C chemokines: cell sources and physiopathological implications.

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Immune-mediated disease pathogenesis in respiratory syncytial virus infection

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

RSV-induced immunopathology: dynamic interplay between the virus and host immune response

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Fractalkine-mediated endothelial cell injury by NK cells

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Respiratory syncytial virus: the virus, the disease and the immune response

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Respiratory syncytial virus immunobiology and pathogenesis

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Interferon-gamma stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by ant

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G.

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.

29 December 2022

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.176.3.1600

10.4049/JIMMUNOL.176.3.1600

29 December 2022

Identifiers

DOI

1 reference

2 August 2017

1 reference